High-resolution Imaging of Corneal Lesions With Optical Coherence Tomography (OCT) - A Pilot Study
Study Details
Study Description
Brief Summary
Corneal lesions such as corneal abrasions and corneal infiltrates are common in clinical practice. The current study seeks to investigate whether high-resolution OCT is suitable for imaging of these corneal lesions. The present study has the character of a pilot study and the results are intended to be used to develop a standardized protocol for imaging and analysis of these corneal lesions. Based on this protocol, further studies investigating the pathophysiology of corneal lesions or evaluating therapeutic success can be planned.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: 10 patients with corneal abrasions
|
Device: Optical Coherence Tomography (OCT)
High-resolution OCT imaging of the cornea
Other: Slit lamp biomicroscopy
Slit lamp biomicroscopy with fluorescein staining and slit lamp photograph
|
Experimental: 10 patients with corneal infiltrates
|
Device: Optical Coherence Tomography (OCT)
High-resolution OCT imaging of the cornea
Other: Slit lamp biomicroscopy
Slit lamp biomicroscopy with fluorescein staining and slit lamp photograph
|
Outcome Measures
Primary Outcome Measures
- Imaging of corneal abrasions and infiltrates [1 day]
The aim of this pilot study is to investigate whether imaging of these corneal alterations is possible.
Secondary Outcome Measures
- Size and depth of corneal lesions as assessed with high-resolution OCT [1 day]
The volume and size of corneal lesions or infiltrates will be assessed using a specific software.
- Slit lamp biomicroscopy with fluorescein staining [1 day]
The volume and size of corneal lesions or infiltrates will be assessed.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Men and women aged over 18 years
-
Newly diagnosed corneal abrasion or corneal infiltrate
Exclusion Criteria:
-
Recurrent corneal erosion
-
Participation in a clinical trial in the previous 3 weeks
-
Presence of any abnormalities preventing reliable measurements as judged by the investigator
-
Any contraindication for topical application of Novain 0.4% eye drops for topical anesthesia or of Minims-Fluorescein Sodium eye drops for fluorescein staining
-
Pregnancy, planned pregnancy or lactating
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Clinical Pharmacology, Medical University of Vienna | Vienna | Austria | 1090 |
Sponsors and Collaborators
- Medical University of Vienna
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- OPHT-041112